NM_001395490.1:c.3572T>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001395490.1(TRERF1):c.3572T>C(p.Val1191Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395490.1 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRERF1 | NM_001395490.1 | c.3572T>C | p.Val1191Ala | missense_variant | Exon 18 of 18 | ENST00000695948.1 | NP_001382419.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRERF1 | ENST00000695948.1 | c.3572T>C | p.Val1191Ala | missense_variant | Exon 18 of 18 | NM_001395490.1 | ENSP00000512293.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251466 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727242 show subpopulations
GnomAD4 genome AF: 0.000138 AC: 21AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74352 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3536T>C (p.V1179A) alteration is located in exon 18 (coding exon 14) of the TRERF1 gene. This alteration results from a T to C substitution at nucleotide position 3536, causing the valine (V) at amino acid position 1179 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at